Welcome to Country
Official Opening, Governor of Queensland, Ms Penelope Wensley AC
Stirling Moorey has been identified as the Wiley-Blackwell speaker - he will be submitting a paper to the Wiley-Blackwell journal Psycho-Oncology based on this lecture.
These presentations will conclude with a Q&A session, Chaired by Phyllis Butow
The inaugural President’s Plenary aims to provide a platform for dissemination of important initiatives and achievements of interest to cancer professionals globally. IPOS’s Vision, which was established in 2004, is that all cancer patients and their families throughout the world receive optimal psychosocial care at all stages of disease and survivorship. The aim is also for IPOS members and associates to provide the pre-eminent international resource for the dissemination of information and development of interventions that reduce cancers related to lifestyle and behaviours, and optimize care. Important initiatives have been driven by focal needs to see Psychosocial care available as a seamless part of holistic multi-disciplinary quality cancer care and Life-extending lifestyle changes promoted and supported through the expertise of behavioural and social scientists. In keeping with WHO targets that there is ‘no health without mental health’ IPOS has declared that cancer health must include mental health. This is in line with the patients’ declaration to ‘See us - not our disease.’
11:00 AM
Welcome / Opening
11:05 AM Maggie Watson - “The William Rudder Memorial Lecture - Impact through Endorsement: Global Engagement on the IPOS Quality Standard”
11:35 AM Barry Bultz - IPOS International standard for quality cancer care: Distress as the 6th vital sign
11:45 AM Bill Breitbart - Psychosocial care as a human right
11:55 AM Luigi Grassi - Federation of National Societies
12:05 PM Devon McGoldrick - LIVESTRONG
12:15 PM Jeff Dunn - Advocacy/UICC
12:25 PM Q&A / Session Close
With an emphasis on research that informs translation, this session will focus on survivorship care interventions. The four presentations showcase the depth and breadth of work taking place across Australia, including a focus on patient preferences for models of post-treatment care, evaluation of nurse-led and shared care models, and interventions to improve exercise and weight control.
Including:
IPOS – Annual Business Meeting
CCQ - Proscan for couples investigator meeting
COSA – Oncology Social Work (OSWA) AGM (M4)
COSA – Psycho-Oncology Group (OZPOS) AGM (M3)
COSA – Familial Cancer Group AGM (M7&8)
COSA – Clinical Research Professionals Group AGM (M9)
COSA – Medical Oncology Group (MOGA) Meeting (P4)
COSA – Cancer Pharmacists Group AGM (P2)
(Scientific theme: Survivorship – Psychological Issues)
(Scientific theme: Screening for Disease)
(Scientific theme: Psychometric evaluations)
(Scientific theme: Paediatric Issues)
(Scientific theme: Advanced cancer)
Including Joint Poster Discussion 3:20 - 4:00pm
The discussant, Ben Britton (Psycho-Oncology Service, Calvary Mater Newcastle) will present on the integration of self-directed interventions in clinical practice and how these can be used by health professionals to enhance the care provided to patients and their families. To our knowledge, this is the first symposium on self-directed interventions at IPOS.
The aim of this symposium is to provide a forum for discussion of the complex supportive care needs of patients with head and neck cancer, including discussion of ways to translate evidence into clinical practice.
People affected by cancer, health professionals involved in their care and the health system have an interest in long-term outcomes of clinical trials.
When people are followed for their long-term survival outcomes (sometimes 15-30 years or more) the costs and logistics of follow-up can be complicated and it is difficult to obtain funding for this.
In an era of electronic databases, e-medical records and personal health records it seems that long-term follow-up could be streamlined, saving resources and ensuring more complete data collection.
However, we need to be designing and planning our clinical trials in a way that facilitates smooth and log-cost data linkage.
This session aims to address the current problems and potential solutions, it will also consider the workforce issues relevant to clinical trials.
Chair: Judy Bauer